/Companies

Wayfinder Biosciences

6 known investors

Find your way into Wayfinder Biosciences

925 people in our graph share verified history with the Wayfinder Biosciences team — schools, employers, funds. One of them is your warm intro.

Joe Horsmanunlockedknows Jason Fontana · together at University of Washington (overlapped)
×10knows the team · via University of Washington
knows the team · via Engineering Biology Research Consortium

Wayfinder develops RNA-targeting small molecule therapies using expertise in RNA biophysics, molecular biology, and machine learning to discover treatments for currently incurable diseases.

Founders & leadership

JFJason Fontana
Jason FontanaFounder & CEOJason Fontana is founder and CEO of Wayfinder Biosciences, which discovers small molecule therapeutics targeting RNA structures using high-throughput screening and machine learning approaches.
DSDavid Sparkman-Yager
David Sparkman-YagerFounder & CTO
CHChuhern Hwang
Chuhern HwangFounder & Head of Drug Discovery

Investors · 6

Frequently asked questions

What does Wayfinder Biosciences do?
Wayfinder develops RNA-targeting small molecule therapies using expertise in RNA biophysics, molecular biology, and machine learning to discover treatments for currently incurable diseases.
Who founded Wayfinder Biosciences?
Wayfinder Biosciences was founded by Jason Fontana, David Sparkman-Yager, Chuhern Hwang.
Who are Wayfinder Biosciences's investors?
Wayfinder Biosciences's investors include Notation Capital, Social Starts, BoxOne Ventures, Divergent Capital, Entrepreneur First, Exor Ventures.